Contact Information
Company Information
Company
Acrivon Therapeutics, Inc.
Technologies
Mimecast
Outlook
CloudFlare Hosting
BambooHR
Google Tag Manager
New Relic
reCAPTCHA
Mobile Friendly
Google Font API
WordPress.org
Circle
Remote
Keywords
proteomics
drug development
multiplex tissue imaging
biomarker discovery
precision medicine
oncology
therapeutics
biotechnology: pharmaceutical preparations
health care
biotechnology research
precision oncology
targeted therapies
ap3 platform
oncosignature
biomarker identification
patient selection
drug response prediction
chk1/2 inhibitor
clinical trials
fda fast track
cancer treatment
tumor profiling
drug resistance mechanisms
personalized medicine
molecular pharmacology
preclinical studies
clinical development
tumor biopsy tests
drug efficacy
selective inhibitors
immuno-oncology
biopharmaceutical
r&d
oncogenic signaling
therapeutic candidates
phosphoproteomics
drug sensitivity
patient outcome improvement
tumor cell protein signaling
monotherapy activity
biomarker validation
rational drug combinations
pharmacodynamic biomarkers
metastatic cancer
ovarian cancer
endometrial cancer
solid tumors
phosphorylation dynamics
clinical pharmacology
drug profiling
resistance pathways
potentially registrational trials
companion diagnostics
biomarker-driven therapies
investigational drugs
therapeutic development
drug optimization
oncology pipeline
hospital & health care
health
wellness & fitness
research & development
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans